Unlock stock picks and a broker-level newsfeed that powers Wall Street.
13.07
-0.01
(-0.08%)
At close: April 3 at 4:00:02 PM EDT
13.07
0.00
(0.00%)
After hours: April 3 at 5:38:20 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
256,182
256,182
216,389
181,383
147,464
Cost of Revenue
64,693
64,693
51,954
32,117
28,024
Gross Profit
191,489
191,489
164,435
149,266
119,440
Operating Expense
232,267
232,267
210,100
183,973
130,215
Operating Income
-40,778
-40,778
-45,665
-34,707
-10,775
Net Non Operating Interest Income Expense
-11,531
-11,531
-5,165
-4,129
-1,719
Other Income Expense
-1,171
-1,171
-6,491
-26,877
-486
Pretax Income
-53,480
-53,480
-57,321
-65,713
-12,980
Tax Provision
1,159
1,159
213
-64
713
Net Income Common Stockholders
-54,639
-54,639
-57,534
-65,649
-13,693
Diluted NI Available to Com Stockholders
-54,639
-54,639
-57,534
-65,649
-13,693
Basic EPS
-0.66
--
-0.70
-0.87
-0.18
Diluted EPS
-0.66
--
-0.70
-0.87
-0.18
Basic Average Shares
83,311.25
--
82,087.33
77,770.59
76,447.29
Diluted Average Shares
83,311.25
--
82,087.33
77,770.59
76,447.29
Total Operating Income as Reported
-40,778
-40,778
-45,665
-61,707
-10,775
Total Expenses
296,960
296,960
262,054
216,090
158,239
Net Income from Continuing & Discontinued Operation
-54,639
-54,639
-57,534
-65,649
-13,693
Normalized Income
-54,639
-54,639
-53,340.68
-38,675.30
-13,693
Interest Expense
11,531
11,531
5,165
4,129
1,719
Net Interest Income
-11,531
-11,531
-5,165
-4,129
-1,719
EBIT
-41,949
-41,949
-52,156
-61,584
-11,261
EBITDA
-23,403
-23,403
-36,614
-47,856
-2,300
Reconciled Cost of Revenue
64,693
64,693
51,954
32,117
28,024
Reconciled Depreciation
18,546
18,546
15,542
13,728
8,961
Net Income from Continuing Operation Net Minority Interest
-54,639
-54,639
-57,534
-65,649
-13,693
Total Unusual Items Excluding Goodwill
--
--
-5,308
-27,000
--
Total Unusual Items
--
--
-5,308
-27,000
--
Normalized EBITDA
-23,403
-23,403
-31,306
-20,856
-2,300
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
--
--
-1,114.68
-26.30
--
12/31/2021 - 10/15/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TMCI Treace Medical Concepts, Inc.
7.83
-5.89%
LIVN LivaNova PLC
37.48
-5.11%
BVS Bioventus Inc.
9.15
-3.79%
ATEC Alphatec Holdings, Inc.
10.21
-2.30%
LUNG Pulmonx Corporation
6.76
-0.88%
AVNS Avanos Medical, Inc.
14.03
-3.37%
OFIX Orthofix Medical Inc.
15.54
-4.66%
SNN Smith & Nephew plc
27.94
-0.68%
NVRO Nevro Corp.
5.84
0.00%
LNSR LENSAR, Inc.
14.06
-0.28%